Clinical research has always struggled with enrollment. Studies consistently cite patient recruitment as the biggest challenge in conducting trials; timelines slip, budgets balloon, and some trials fail entirely because they can't find enough participants.

The numbers reflect how deep the problem runs: 80% of clinical trials miss enrollment timelines, recruitment can consume 30-40% of trial budgets, and the average trial screens 10 patients to enroll one. These aren't new problems. They've persisted for decades despite significant investment in trying to solve them.

The reason they persist comes down to structure. Traditional recruitment relies on intermediaries; patients learn about trials through their doctors, through advertising, or through site outreach. Every intermediary adds friction, delay, and cost. The model wasn't designed for the volume and specificity of modern research, and it shows.

The Patient-Directed Alternative

The 21st Century Cures Act established that patients have the right to access their health data through authorized applications. That regulatory foundation opens a fundamentally different recruitment model — one where patients don't wait to be found.

Instead of researchers searching for patients through sites and advertising, patients authorize platforms to match them with relevant studies based on their own clinical data. The direction of the relationship inverts.

In practice, this looks like:

1. A patient interested in contributing to research authorizes a platform to access their health records

2. The platform compares their clinical data: diagnoses, medications, lab values, medical history, against eligibility criteria for active trials

3. When there's a potential match, the patient is notified with trial details and next steps

4. Initial eligibility screening happens automatically using authorized data, before any site visit

5. Only likely-eligible patients proceed to final screening and enrollment

The result: faster identification of eligible patients, a dramatically lower screen-to-enroll ratio, and reach that isn't limited to patients already connected to research sites.

What This Requires

For this model to work, research platforms need access to comprehensive patient clinical data with patient authorization. That means integrating with the EHR systems where that data actually lives: Epic, Cerner, athena, eClinicalWorks, and others. It means handling FHIR APIs, authentication flows, and data normalization across systems that don't behave consistently.

This is what Consolidate Health enables. Our API provides access to patient-authorized clinical data across major EHR systems, returning the data research platforms need for eligibility matching: diagnoses, procedures, medications, lab results, and medical history, normalized and current, from wherever the patient has received care, not just one health system.

Where This Creates Value for CROs and Research Organizations

The infrastructure unlocks several distinct use cases:

• Trial matching platforms: Applications that match patients with relevant trials based on their clinical profiles. Patients authorize access; the platform identifies opportunities automatically.

• Pre-screening tools: Access patient data before site visits to filter for likely-eligible candidates, reducing screen failures and the burden on sites.

• Patient intake modernization: Instead of patients filling out paper forms from memory, pull current medications, allergies, and medical history directly from their records.

• Decentralized trial support: Enable trials where patients participate remotely. Patient-authorized data provides clinical context without requiring site visits.

• Real-world evidence collection: With patient consent, access clinical data for outcomes research and post-market studies.

Better for Researchers. Better for Patients.

Patients consistently say they want to contribute to research. The current system just makes it harder than it should be; they don't know which trials exist, don't know which ones they'd qualify for, and face real travel and time burdens just to get screened.

Patient-directed matching changes that. Patients can discover relevant research opportunities, pre-qualify based on their own data, and make informed decisions about participation without navigating the full site-visit process just to find out if they're eligible.

The shift from researchers finding patients to patients finding research changes the dynamic for everyone involved.

The Infrastructure Is Here

The regulatory framework exists. The Cures Act established patient data rights. FHIR APIs and OAuth authorization provide the technical standards. What's been missing is infrastructure that connects patient data to research platforms in a scalable, compliant way.

That infrastructure now exists. The question is which research organizations move first.